Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Sempra a un objectif de cours consensus de $91.83, basé sur les évaluations des 18 analystes. Le plus élevé est de $165 attribué par B of A Securities le mars 28, 2023, et le plus bas est de $75 attribué par Jefferies le avril 15, 2025. Les 3 dernières évaluations d'analystes ont été publiées par Barclays, Citigroup et Barclays le août 26, 2025, août 4, 2025 et juillet 10, 2025. Avec un objectif de cours moyen de $77 entre Barclays, Citigroup et Barclays, il y a une variation implicite de -5.45% downside pour Sempra à partir de ces dernières évaluations d'analystes.
1calculé à partir des notes des analystes
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
08/26/2025 | -1.77% | Barclays | $71 → $80 | Maintains | Equal-Weight | |||
08/04/2025 | -1.77% | Citigroup | $70 → $80 | Maintains | Neutral | |||
07/10/2025 | -12.82% | Barclays | $72 → $71 | Maintains | Equal-Weight | |||
06/18/2025 | 8.06% | Morgan Stanley | $87 → $88 | Maintains | Overweight | |||
05/22/2025 | 6.83% | Morgan Stanley | $89 → $87 | Maintains | Overweight | |||
05/12/2025 | -0.54% | BMO Capital | $78 → $81 | Maintains | Outperform | |||
04/23/2025 | 9.28% | Morgan Stanley | $86 → $89 | Maintains | Overweight | |||
04/15/2025 | -7.91% | Jefferies | $77 → $75 | Maintains | Hold | |||
04/09/2025 | -14.05% | Citigroup | $93 → $70 | Maintains | Neutral | |||
03/26/2025 | 4.37% | Wells Fargo | $88 → $85 | Maintains | Overweight | |||
03/20/2025 | 5.6% | Morgan Stanley | $85 → $86 | Maintains | Overweight | |||
03/04/2025 | -4.22% | BMO Capital | $92 → $78 | Maintains | Outperform | |||
03/03/2025 | -5.45% | Jefferies | $96 → $77 | Downgrade | Buy → Hold | |||
02/27/2025 | -11.59% | Barclays | $95 → $72 | Downgrade | Overweight → Equal-Weight | |||
02/26/2025 | -6.68% | Goldman Sachs | $99 → $76 | Downgrade | Buy → Neutral | |||
02/26/2025 | -6.68% | Mizuho | $92 → $76 | Maintains | Outperform | |||
02/26/2025 | 6.83% | Guggenheim | $95 → $87 | Maintains | Buy | |||
02/26/2025 | 4.37% | Morgan Stanley | $100 → $85 | Maintains | Overweight | |||
02/26/2025 | -4.22% | UBS | $95 → $78 | Downgrade | Buy → Neutral | |||
02/26/2025 | 8.06% | Wells Fargo | $96 → $88 | Maintains | Overweight | |||
01/27/2025 | 16.65% | Barclays | $99 → $95 | Maintains | Overweight | |||
12/13/2024 | 20.33% | Morgan Stanley | $85 → $98 | Upgrade | Equal-Weight → Overweight | |||
12/02/2024 | 21.56% | Barclays | $89 → $99 | Maintains | Overweight | |||
11/07/2024 | 17.88% | Wells Fargo | $87 → $96 | Maintains | Overweight | |||
11/07/2024 | 8.06% | Evercore ISI Group | $84 → $88 | Maintains | Outperform | |||
10/24/2024 | 20.33% | Jefferies | → $98 | Initiates | → Buy | |||
10/21/2024 | 17.88% | BMO Capital | $93 → $96 | Maintains | Outperform | |||
10/01/2024 | 9.28% | Barclays | $87 → $89 | Maintains | Overweight | |||
09/25/2024 | 4.37% | Morgan Stanley | $80 → $85 | Maintains | Equal-Weight | |||
09/12/2024 | 15.42% | B of A Securities | → $94 | Reinstates | → Buy | |||
09/12/2024 | 14.19% | BMO Capital | $90 → $93 | Maintains | Outperform | |||
08/23/2024 | -1.77% | Morgan Stanley | $77 → $80 | Maintains | Equal-Weight | |||
08/13/2024 | 6.83% | Barclays | $81 → $87 | Maintains | Overweight | |||
08/07/2024 | 3.14% | Evercore ISI Group | $83 → $84 | Maintains | Outperform | |||
07/10/2024 | 3.14% | BMO Capital | $86 → $84 | Maintains | Outperform | |||
06/24/2024 | -6.68% | Morgan Stanley | $79 → $76 | Maintains | Equal-Weight | |||
05/29/2024 | -3% | Ladenburg Thalmann | $81.5 → $79 | Maintains | Buy | |||
05/17/2024 | 5.6% | Mizuho | $79 → $86 | Maintains | Buy | |||
05/08/2024 | 3.14% | Wells Fargo | $79 → $84 | Maintains | Overweight | |||
03/21/2024 | -7.91% | Morgan Stanley | $74 → $75 | Maintains | Equal-Weight | |||
03/14/2024 | -3% | Barclays | $77 → $79 | Maintains | Overweight | |||
03/06/2024 | 0.69% | RBC Capital | $82 → $82 | Reiterates | Outperform → Outperform | |||
01/25/2024 | -3% | Mizuho | $83 → $79 | Maintains | Buy | |||
01/22/2024 | -5.45% | Barclays | $76 → $77 | Maintains | Overweight | |||
01/11/2024 | 3.14% | BMO Capital | $76 → $84 | Upgrade | Market Perform → Outperform | |||
01/03/2024 | 0.07% | Ladenburg Thalmann | → $81.5 | Initiates | → Buy | |||
12/12/2023 | 5.6% | JP Morgan | $78 → $86 | Upgrade | Neutral → Overweight | |||
11/21/2023 | -10.36% | Morgan Stanley | $75 → $73 | Maintains | Equal-Weight | |||
10/25/2023 | -7.91% | Morgan Stanley | $78 → $75 | Maintains | Equal-Weight | |||
10/24/2023 | -6.68% | Barclays | $78 → $76 | Maintains | Overweight | |||
10/17/2023 | -4.22% | JP Morgan | $82 → $78 | Maintains | Neutral | |||
10/04/2023 | 9.28% | UBS | $95 → $89 | Maintains | Buy | |||
09/21/2023 | -4.22% | Morgan Stanley | $76 → $78 | Maintains | Equal-Weight | |||
09/06/2023 | 0.69% | RBC Capital | $91 → $82 | Maintains | Outperform | |||
08/23/2023 | -6.68% | Morgan Stanley | $79 → $76 | Maintains | Equal-Weight | |||
08/23/2023 | 91.55% | Barclays | → $156 | Initiates | → Overweight | |||
08/07/2023 | 96.46% | BMO Capital | $168 → $160 | Maintains | Market Perform | |||
08/04/2023 | 103.83% | Wells Fargo | $174 → $166 | Maintains | Overweight | |||
07/21/2023 | 94.01% | Morgan Stanley | $158 → $158 | Reiterates | Equal-Weight → Equal-Weight | |||
07/11/2023 | 111.2% | Guggenheim | → $172 | Reiterates | Buy → Buy | |||
07/07/2023 | 111.2% | Guggenheim | $174 → $172 | Maintains | Buy | |||
06/23/2023 | 94.01% | Morgan Stanley | $163 → $158 | Maintains | Equal-Weight | |||
06/08/2023 | 118.57% | Goldman Sachs | → $178 | Initiates | → Buy | |||
05/22/2023 | 100.15% | Morgan Stanley | $164 → $163 | Maintains | Equal-Weight | |||
04/20/2023 | 101.38% | Morgan Stanley | $150 → $164 | Maintains | Equal-Weight | |||
03/28/2023 | 102.6% | B of A Securities | $173 → $165 | Maintains | Buy | |||
03/21/2023 | 84.18% | Morgan Stanley | $158 → $150 | Maintains | Equal-Weight | |||
03/01/2023 | 113.65% | Wells Fargo | $180 → $174 | Maintains | Overweight | |||
03/01/2023 | 103.83% | BMO Capital | $169 → $166 | Maintains | Market Perform | |||
02/22/2023 | 94.01% | Morgan Stanley | $160 → $158 | Maintains | Equal-Weight | |||
01/23/2023 | 96.46% | Morgan Stanley | $162 → $160 | Maintains | Equal-Weight | |||
12/15/2022 | 98.92% | Morgan Stanley | $153 → $162 | Maintains | Equal-Weight | |||
12/14/2022 | 121.02% | Wells Fargo | $168 → $180 | Maintains | Overweight | |||
11/11/2022 | 87.87% | Morgan Stanley | $144 → $153 | Maintains | Equal-Weight | |||
10/21/2022 | 76.82% | Morgan Stanley | $165 → $144 | Maintains | Equal-Weight | |||
10/19/2022 | 106.29% | Wells Fargo | $189 → $168 | Maintains | Overweight | |||
10/03/2022 | 97.69% | Mizuho | $173 → $161 | Maintains | Buy | |||
09/22/2022 | 102.6% | Morgan Stanley | $169 → $165 | Maintains | Equal-Weight | |||
09/15/2022 | 132.07% | Wells Fargo | $184 → $189 | Maintains | Overweight |
Le dernier objectif de prix pour Sempra (NYSE:SRE) a été rapporté par Barclays le août 26, 2025. Le cabinet d'analystes a fixé un objectif de prix pour $80.00 s'attendant à ce que SRE se fall dans les 12 prochains mois (un possible changement de -1.77% downside). 31 cabinets d'analystes ont rapporté des notes au cours de la dernière année.
La dernière note d'analyste pour Sempra (NYSE:SRE) a été fournie par Barclays, et Sempra maintenu leur note equal-weight.
La dernière amélioration pour Sempra a eu lieu le décembre 13, 2024 lorsque Morgan Stanley a augmenté leur objectif de prix à $98. Morgan Stanley avait précédemment an equal-weight pour Sempra.
La dernière réduction pour Sempra a eu lieu le mars 3, 2025 lorsque Jefferies a changé leur objectif de prix de $96 à $77 pour Sempra.
Les analystes arrivent à des évaluations d'actions après avoir effectué des recherches approfondies, ce qui inclut l'examen des états financiers publics, la discussion avec les dirigeants et les clients de Sempra, et l'écoute des conférences téléphoniques sur les résultats. La plupart des analystes font cela tous les trois mois, vous devriez donc obtenir 4 notes par entreprise par société chaque année. La dernière note pour Sempra a été déposée le août 26, 2025, donc vous devriez vous attendre à ce que la prochaine note soit disponible vers août 26, 2026.
Bien que les évaluations soient subjectives et changeront, la dernière note de Sempra (SRE) était un maintenu avec un objectif de prix de $71.00 à $80.00. Le prix actuel de Sempra (SRE) est de $81.44, ce qui est out of la fourchette prédite par l'analyste.
Parcourir notes d'analystes et objectifs de cours sur toutes les actions.